Literature DB >> 15024385

p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding.

Eilyn R Lacy1, Igor Filippov, William S Lewis, Steve Otieno, Limin Xiao, Sonja Weiss, Ludger Hengst, Richard W Kriwacki.   

Abstract

p27 controls cell proliferation by binding and regulating nuclear cyclin-dependent kinases (CDKs). In addition, p27 interacts with other nuclear and cytoplasmic targets and has diverse biological functions. We seek to understand how the structural and dynamic properties of p27 mediate its several functions. We show that, despite showing disorder before binding its targets, p27 has nascent secondary structure that may have a function in molecular recognition. Binding to Cdk2-cyclin A is accompanied by p27 folding, and kinetic data suggest a sequential mechanism that is initiated by binding to cyclin A. p27 regulates CDK-cyclin complexes involved directly in cell cycle control and does not interact with other closely related CDKs. We show that p27-cyclin interactions are an important determinant of this specificity and propose that the homologous cell cycle regulators p21 and p57 function by a similar sequential, folding-on-binding mechanism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024385     DOI: 10.1038/nsmb746

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  125 in total

Review 1.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

2.  Electrostatically accelerated coupled binding and folding of intrinsically disordered proteins.

Authors:  Debabani Ganguly; Steve Otieno; Brett Waddell; Luigi Iconaru; Richard W Kriwacki; Jianhan Chen
Journal:  J Mol Biol       Date:  2012-06-19       Impact factor: 5.469

3.  Mechanism and rate constants of the Cdc42 GTPase binding with intrinsically disordered effectors.

Authors:  Xiaodong Pang; Huan-Xiang Zhou
Journal:  Proteins       Date:  2016-03-09

Review 4.  Process of protein transport by the type III secretion system.

Authors:  Partho Ghosh
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

5.  p25alpha is flexible but natively folded and binds tubulin with oligomeric stoichiometry.

Authors:  Daniel E Otzen; Ditte M S Lundvig; Reinhard Wimmer; Lotte H Nielsen; Jakob R Pedersen; Poul H Jensen
Journal:  Protein Sci       Date:  2005-05-09       Impact factor: 6.725

6.  Quantitative relation between intermolecular and intramolecular binding of pro-rich peptides to SH3 domains.

Authors:  Huan-Xiang Zhou
Journal:  Biophys J       Date:  2006-08-04       Impact factor: 4.033

7.  Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model.

Authors:  Kit I Tong; Yasutake Katoh; Hideki Kusunoki; Ken Itoh; Toshiyuki Tanaka; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  CDK inhibitors selectively diminish cell cycle controlled activation of the histone H4 gene promoter by p220NPAT and HiNF-P.

Authors:  Partha Mitra; Prachi N Ghule; Margaretha van der Deen; Ricardo Medina; Rong-Lin Xie; William F Holmes; Xin Ye; Keiichi I Nakayama; J Wade Harper; Janet L Stein; Gary S Stein; Andre J van Wijnen
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

9.  P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases.

Authors:  Debora Bencivenga; Annunziata Tramontano; Alessia Borgia; Aide Negri; Ilaria Caldarelli; Adriana Oliva; Silverio Perrotta; Fulvio Della Ragione; Adriana Borriello
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Cytoplasmic expression of p27(kip1) is associated with a favourable prognosis in colorectal cancer patients.

Authors:  Nicholas F S Watson; Lindy G Durrant; John H Scholefield; Zahra Madjd; Duncan Scrimgeour; Ian Spendlove; Ian O Ellis; Poulam M Patel
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.